炎症性肠病基础研究与治疗的进展

被引:8
作者
欧阳钦
机构
[1] 四川大学华西医院消化内科
关键词
D O I
暂无
中图分类号
R686 [筋腱、韧带、滑囊疾病及损伤];
学科分类号
100220 [骨科学];
摘要
<正> 近年来,随着我国人民生活水平的提高与城市化、工业化和现代化的进程,炎症性肠病(IBD)无论是溃疡性结肠炎(UC)还是克罗恩病(CD)都明显增多。5年前全国一项以医院为基础的多中心临床研究显示,住院病例数近14年较过去增加近5倍,由此推测的患病率分别为UC11.6/10~5及CD1.4/10~5,与日本、韩国和新加坡的患病率接近。最近几年文献资料显示其患病率还有增加,且CD的增加逐渐明显。这一趋势重复着西方国家上世纪50年代以来的故事,
引用
收藏
相关论文
共 7 条
[1]
中国炎症性肠病诊断治疗规范的共识意见.[J]..中华内科杂志.2008, 01
[2]
Biological Therapies for Inflammatory Bowel Diseases [J].
Rutgeerts, Paul ;
Vermeire, Severine ;
Van Assche, Gert .
GASTROENTEROLOGY, 2009, 136 (04) :1182-1197
[3]
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial [J].
D'Haens, Geert ;
Baert, Filip ;
van Assche, Gert ;
Caenepeel, Philip ;
Vergauwe, Philippe ;
Tuynman, Hans ;
De Vos, Martine ;
van Deventer, Sander ;
Stitt, Larry ;
Donner, Allan ;
Vermeire, Severine ;
Van De Mierop, Frank J. ;
Coche, Jean-Charles R. ;
van der Woude, Janneke ;
Ochsenkuehn, Thomas ;
van Bodegraven, Ad A. ;
van Hootegem, Philippe P. ;
Lambrecht, Guy L. ;
Mana, Fazia ;
Rutgeerts, Paul ;
Feagan, Brian G. ;
Hommes, Daniel .
LANCET, 2008, 371 (9613) :660-667
[4]
Current Directions in IBD Therapy: What Goals Are Feasible With Biological Modifiers? [J].
Sandborn, William J. .
GASTROENTEROLOGY, 2008, 135 (05) :1442-1447
[5]
Inflammatory bowel disease: past, present, and future [J].
Sands, Bruce E. .
JOURNAL OF GASTROENTEROLOGY, 2007, 42 (01) :16-25
[6]
American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease [J].
Lichtenstein, GR ;
Abreu, MT ;
Cohen, R ;
Tremaine, W .
GASTROENTEROLOGY, 2006, 130 (03) :940-987
[7]
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease [J].
Darfeuille-Michaud, A ;
Boudeau, J ;
Bulois, P ;
Neut, C ;
Glasser, AL ;
Barnich, N ;
Bringer, MA ;
Swidsinski, A ;
Beaugerie, L ;
Colombel, JF .
GASTROENTEROLOGY, 2004, 127 (02) :412-421